Showing 461 - 480 results of 770 for search '(( significant increase decrease ) OR ( significant ((a decrease) OR (linear decrease)) ))~', query time: 0.72s Refine Results
  1. 461

    Table 2_Association between DASH diet and metabolic syndrome in US adults: a cross-sectional study.xlsx by Jianing Liu (140090)

    Published 2025
    “…Subsequently, we discovered that DASH levels are significantly negatively correlated with waist circumference (WC), fasting plasma glucose (FPG), triglycerides (TG), and systolic blood pressure (SBP), while exhibiting a positive correlation with high-density lipoprotein cholesterol (HDL-C) through RCS curves and linear regression.…”
  2. 462

    Image 1_Circulating growth differentiation factor-15 concentration and hypertension risk: a dose-response meta-analysis.tif by Zhengqing Yu (12641890)

    Published 2025
    “…</p>Conclusions<p>Circulating GDF-15 is positively and non-linearly associated with the prevalence of hypertension, with a plateau or slight decline after reaching a certain GDF-15 dose. …”
  3. 463

    Image 2_Circulating growth differentiation factor-15 concentration and hypertension risk: a dose-response meta-analysis.tif by Zhengqing Yu (12641890)

    Published 2025
    “…</p>Conclusions<p>Circulating GDF-15 is positively and non-linearly associated with the prevalence of hypertension, with a plateau or slight decline after reaching a certain GDF-15 dose. …”
  4. 464

    Table 4_Circulating growth differentiation factor-15 concentration and hypertension risk: a dose-response meta-analysis.docx by Zhengqing Yu (12641890)

    Published 2025
    “…</p>Conclusions<p>Circulating GDF-15 is positively and non-linearly associated with the prevalence of hypertension, with a plateau or slight decline after reaching a certain GDF-15 dose. …”
  5. 465

    Table 1_Circulating growth differentiation factor-15 concentration and hypertension risk: a dose-response meta-analysis.docx by Zhengqing Yu (12641890)

    Published 2025
    “…</p>Conclusions<p>Circulating GDF-15 is positively and non-linearly associated with the prevalence of hypertension, with a plateau or slight decline after reaching a certain GDF-15 dose. …”
  6. 466

    Table 3_Circulating growth differentiation factor-15 concentration and hypertension risk: a dose-response meta-analysis.docx by Zhengqing Yu (12641890)

    Published 2025
    “…</p>Conclusions<p>Circulating GDF-15 is positively and non-linearly associated with the prevalence of hypertension, with a plateau or slight decline after reaching a certain GDF-15 dose. …”
  7. 467

    Table 2_Circulating growth differentiation factor-15 concentration and hypertension risk: a dose-response meta-analysis.docx by Zhengqing Yu (12641890)

    Published 2025
    “…</p>Conclusions<p>Circulating GDF-15 is positively and non-linearly associated with the prevalence of hypertension, with a plateau or slight decline after reaching a certain GDF-15 dose. …”
  8. 468

    Image 2_Association of high consumption of soy products with the risk of cognitive impairment and major neurocognitive disorders: a systematic review and dose-response meta-analysi... by Jialin Yu (131558)

    Published 2025
    “…The dose-response meta-analysis indicated that a 1-g per day increase in the consumption of soy and natto demonstrated a correlation with an 8 and 14% decrease in the likelihood of developing major neurocognitive disorder, respectively. …”
  9. 469

    Table 1_Association of high consumption of soy products with the risk of cognitive impairment and major neurocognitive disorders: a systematic review and dose-response meta-analysi... by Jialin Yu (131558)

    Published 2025
    “…The dose-response meta-analysis indicated that a 1-g per day increase in the consumption of soy and natto demonstrated a correlation with an 8 and 14% decrease in the likelihood of developing major neurocognitive disorder, respectively. …”
  10. 470

    Image 1_Association of high consumption of soy products with the risk of cognitive impairment and major neurocognitive disorders: a systematic review and dose-response meta-analysi... by Jialin Yu (131558)

    Published 2025
    “…The dose-response meta-analysis indicated that a 1-g per day increase in the consumption of soy and natto demonstrated a correlation with an 8 and 14% decrease in the likelihood of developing major neurocognitive disorder, respectively. …”
  11. 471

    Supplementary Material for: Association between serum albumin to creatinine ratio and readmission in elderly heart failure patients: A Retrospective Cohort Study by Guo L. (3722611)

    Published 2024
    “…Subgroup analysis showed no significant interactions. A nonlinear relationship was observed between the sACR and readmission. …”
  12. 472

    Supplementary file 1_Global burden of skin cancer and its subtypes: a comprehensive analysis from 1990 to 2021 with projections to 2040.pdf by Keyue Chen (2523160)

    Published 2025
    “…</p>Results<p>First, skin cancer ASIR increased from 1990 to 2021, while ASDR significantly decreased. …”
  13. 473

    Table 1_Association of brain-derived neurotrophic factor levels at different trimesters and new-onset depressive symptom in the third trimester among pregnant women: a longitudinal... by Yue-rong Zhang (21838784)

    Published 2025
    “…The average serum BDNF level was highest in the first trimester and lowest in the second trimester. Each 1 pg/mL increase of first trimester BDNF was associated with a 43% decrease in the risk of prenatal depressive symptoms (95% confidence interval [95% CI]: 0.51, 0.65); each 1 pg/mL increase of second trimester BDNF was a 39% decrease in the risk of prenatal depressive symptoms (95% CI: 0.54, 0.68); each 1 pg/mL increase of third trimester BDNF was associated with a 36% decrease in the risk of prenatal depressive symptoms (95% CI: 0.58, 0.71).…”
  14. 474

    Table 1_Association between platelet count and 30-day in-hospital mortality among intensive care unit patients with sepsis: a multicenter retrospective cohort study.docx by Jun Wang (5906)

    Published 2025
    “…Below this threshold, each 10 × 10⁹/L increase in platelet count was associated with a 6% decrease in mortality risk (adjusted OR 0.94, 95% CI 0.93–0.95, p < 0.0001), while above it, each 10 × 10⁹/L increase was associated with a 1% increase in mortality risk (adjusted OR 1.01, 95% CI 1.00–1.01, p = 0.0153).…”
  15. 475

    Table 2_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.xlsx by Xianyu Dai (18939514)

    Published 2025
    “…The median age among these cases was 65 years, with males comprising 53.4%. There were significant annual increases in UR reports associated with antineoplastic agents (0.19% per year) and antidiabetic drugs (0.09% per year), while reports linked to bronchodilators decreased (−0.53% per year). …”
  16. 476

    Table 1_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.docx by Xianyu Dai (18939514)

    Published 2025
    “…The median age among these cases was 65 years, with males comprising 53.4%. There were significant annual increases in UR reports associated with antineoplastic agents (0.19% per year) and antidiabetic drugs (0.09% per year), while reports linked to bronchodilators decreased (−0.53% per year). …”
  17. 477

    Table 1_The nonlinear relationship between estimated glomerular filtration rate and cardiovascular disease in US adults: a cross-sectional study from NHANES 2007–2018.docx by Ce Zhou (2257300)

    Published 2024
    “…</p>Results<p>The study revealed a significant non-linear inverse association between eGFR and CVD risk, with a threshold effect observed at 99.3 ml/min/1.73 m². …”
  18. 478

    Table 4_Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018.docx by Huang Yu (5882174)

    Published 2025
    “…Weighted quantile sum (WQS) regression and quantile g-computation (QGC) analyses were employed to evaluate the association between CVH and liver function markers.</p>Results<p>Linear regression analysis showed that each 1-point increase in CVH score was significantly associated with decreased levels of liver enzymes [ALT: −0.200 U/L (95% CI: −0.223, −0.176), AST: −0.043 U/L (−0.062, −0.024), GGT: −0.453 U/L (−0.509, −0.397), ALP: −0.310 U/L (−0.340, −0.281)] and increased levels of albumin [0.040 g/dL (0.036, 0.045)] and AST/ALT ratio [0.0056 (0.0051, 0.0061)]. …”
  19. 479

    Table 2_Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018.docx by Huang Yu (5882174)

    Published 2025
    “…Weighted quantile sum (WQS) regression and quantile g-computation (QGC) analyses were employed to evaluate the association between CVH and liver function markers.</p>Results<p>Linear regression analysis showed that each 1-point increase in CVH score was significantly associated with decreased levels of liver enzymes [ALT: −0.200 U/L (95% CI: −0.223, −0.176), AST: −0.043 U/L (−0.062, −0.024), GGT: −0.453 U/L (−0.509, −0.397), ALP: −0.310 U/L (−0.340, −0.281)] and increased levels of albumin [0.040 g/dL (0.036, 0.045)] and AST/ALT ratio [0.0056 (0.0051, 0.0061)]. …”
  20. 480

    Table 3_Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018.docx by Huang Yu (5882174)

    Published 2025
    “…Weighted quantile sum (WQS) regression and quantile g-computation (QGC) analyses were employed to evaluate the association between CVH and liver function markers.</p>Results<p>Linear regression analysis showed that each 1-point increase in CVH score was significantly associated with decreased levels of liver enzymes [ALT: −0.200 U/L (95% CI: −0.223, −0.176), AST: −0.043 U/L (−0.062, −0.024), GGT: −0.453 U/L (−0.509, −0.397), ALP: −0.310 U/L (−0.340, −0.281)] and increased levels of albumin [0.040 g/dL (0.036, 0.045)] and AST/ALT ratio [0.0056 (0.0051, 0.0061)]. …”